Coronavirus disease 19 (COVID-19) during chemoradiation for locally advanced oropharyngeal squamous cell carcinoma (LA-OPSCC)

Oral Oncol. 2020 Aug:107:104801. doi: 10.1016/j.oraloncology.2020.104801. Epub 2020 May 14.

Authors

Nerina Denaro¹, Anna Maria Merlotti², Marco Carlo Merlano³, Elvio Russi⁴

Affiliations

¹ Santa Croce e Carle General Hospital, Medical Oncology, Via Michele Coppino 26, 12100 Cuneo, Italy.
² Santa Croce e Carle General Hospital Radiation Oncology, Italy. Electronic address: Merlotti.a@ospedale.cuneo.it.
³ IRCCS Candiolo Turin, Consultant Translational and Medical Oncology, Italy.
⁴ Santa Croce e Carle General Hospital, Radiation Oncology, Italy. Electronic address: Russi.e@ospedale.cuneo.it.

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Betacoronavirus / isolation & purification*
COVID-19
Chemoradiotherapy / adverse effects*
Chemoradiotherapy / standards
Clinical Decision-Making
Coronavirus Infections / diagnosis*
Coronavirus Infections / prevention & control
Coronavirus Infections / transmission
Coronavirus Infections / virology
Humans
Infection Control / instrumentation
Infection Control / standards
Infectious Disease Transmission, Patient-to-Professional / prevention & control
Infectious Disease Transmission, Professional-to-Patient / prevention & control
Male
Middle Aged
Neoplasm Staging
Oropharyngeal Neoplasms / complications
Oropharyngeal Neoplasms / pathology
Oropharyngeal Neoplasms / therapy*
Pandemics / prevention & control
Personal Protective Equipment / standards
Pneumonia, Viral / diagnosis*
Pneumonia, Viral / prevention & control
Pneumonia, Viral / transmission
Pneumonia, Viral / virology
SARS-CoV-2
Squamous Cell Carcinoma of Head and Neck / complications
Squamous Cell Carcinoma of Head and Neck / pathology
Squamous Cell Carcinoma of Head and Neck / therapy*
Treatment Outcome